Immune Response (OTCBB: IMNR) Secures Partners for MS Clinical Trials
Immune Response Corporation recently announced on that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a…
Blog
Xechem’s (OTCBB: XKEM) Orphan Drug Status Approved for New Sickle Cell Drug
Recently, the EU approved "Orphan Drug Status" for Xechem International's sickle cell drug dubbed Niprisan, a phytopharmaceutical product that has…
Positron (OTCBB: POSC) May Get a Boost from PET Scanning of Lymphoma Patients
In a recent online edition of Clinical Oncology, PET scanning is introduced for the first time as a standardized method…
Power Air (OTCBB: PWAC) to Commercialize it Zinc Air Fuel Generator
E-mail Power Air (OTCBB: PWAC) recently signed a Memorandum of Understanding (MOU) with Autobotics Inc regarding the recycling of zinc.…
CompuMed (OTCBB: CMPD) Could Boost Revenue with Grants
The FCC has announced a two-year pilot program that would fund up to 85% of the costs for the…
ORAMED PHARMACEUTICL (OTC BB:ORMP.OB)
Understanding diabetes and the role of insulin Diabetes is a common condition in which the amount of glucose (sugar) in…
ZAP (ZAAP) Hopes to Gain Exposure in the Green Market
With Green Fever sweeping the nation, Zap, and electric car manufacturer is looking to capitalize with its new XEBRA XERO…
Wi-Fi TV (WTVI) Looks to Capitalize on User Content Creation
Over the past year new buzzwords have entered into the realm of internet such as Web 2.0 and User Content…
Sierra Gold (SGCP) Prospects Are Good as Goldman Sachs Remains Bullish on Gold
Gold prices over the past week have begun to stabilize and return to their upward trend after a $50 drop…
Intelligentias (ITLI) Stands to Benefit From Proposed ‘Safety Bill’
Intelligentias' wholly-owned subsidiary is currently bolstering its sales marketing force in the likelihood that the ‘Safety Bill’ will pass through…